Event details

Date

Mon 10. Dec 2018

Time

08:30 -

12:45

Language

English

Venue

Novartis Healthcare A/S

Location

Arne Jacobsens Allé 15

2300

Copenhagen S

If you have any questions leading up to the event, feel free to reply to this email: meh@widex.com

conference

BREXIT – a disaster for Danish life science companies?

Registration Deadline: Thu 06. Dec 2018

Novartis Healthcare A/S

Arne Jacobsens Allé 15,

2300

Copenhagen S

Mon 10. Dec 2018

Description

Life Science Law DK invites you to the association's highly topical event on Monday 10 December 2018 (08.30-12.45) on the forthcoming – “hard” - BREXIT, 29 March 2019. The EU and the UK Government has a few days ago negotiated an agreement (see it here), which is now undergoing a political process in the UK. Life Science Law DK is pleased - as the first - to be able to invite to this exciting event, where a number of experts from the United Kingdom and Denmark give their assessments of what Brexit may mean for the interests of Danish life science companies in Denmark and the United Kingdom. For the event, experts will talk about the economic, commercial and legal implications of Brexit. The speakers will focus on both the consequences for companies that have (or expect to have) financial activities in the United Kingdom, as well as on the consequences for Danish companies' commercial interests in Denmark.

Additional details

AUDIENCE

The event is aimed at anyone working in the life science industry who wants to know more about what Brexit may entail. Feel free to invite your colleagues or others in your network with an interest in the life science industry.

Certification

Course certificates corresponding to 3 lessons are issued, which are handed out after the event. If you want to receive one course certificate, please write this in connection with your registration.

Program

8:30-